BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 11341845)

  • 1. Kinetic analysis of matrix metalloproteinase activity using fluorogenic triple-helical substrates.
    Lauer-Fields JL; Broder T; Sritharan T; Chung L; Nagase H; Fields GB
    Biochemistry; 2001 May; 40(19):5795-803. PubMed ID: 11341845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple-helical peptide analysis of collagenolytic protease activity.
    Lauer-Fields JL; Fields GB
    Biol Chem; 2002; 383(7-8):1095-105. PubMed ID: 12437092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of matrix metalloproteinase triple-helical peptidase activity with substrates incorporating fluorogenic L- or D-amino acids.
    Lauer-Fields JL; Kele P; Sui G; Nagase H; Leblanc RM; Fields GB
    Anal Biochem; 2003 Oct; 321(1):105-15. PubMed ID: 12963061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective hydrolysis of triple-helical substrates by matrix metalloproteinase-2 and -9.
    Lauer-Fields JL; Sritharan T; Stack MS; Nagase H; Fields GB
    J Biol Chem; 2003 May; 278(20):18140-5. PubMed ID: 12642591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and characterization of a fluorogenic substrate selectively hydrolyzed by stromelysin 1 (matrix metalloproteinase-3).
    Nagase H; Fields CG; Fields GB
    J Biol Chem; 1994 Aug; 269(33):20952-7. PubMed ID: 8063713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrolysis of triple-helical collagen peptide models by matrix metalloproteinases.
    Lauer-Fields JL; Tuzinski KA; Shimokawa Ki; Nagase H; Fields GB
    J Biol Chem; 2000 May; 275(18):13282-90. PubMed ID: 10788434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase triple-helical peptidase activities are differentially regulated by substrate stability.
    Minond D; Lauer-Fields JL; Nagase H; Fields GB
    Biochemistry; 2004 Sep; 43(36):11474-81. PubMed ID: 15350133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2, a fluorogenic substrate with increased specificity constants for collagenases and tumor necrosis factor converting enzyme.
    Neumann U; Kubota H; Frei K; Ganu V; Leppert D
    Anal Biochem; 2004 May; 328(2):166-73. PubMed ID: 15113693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosite interactions impact matrix metalloproteinase collagen specificities.
    Robichaud TK; Steffensen B; Fields GB
    J Biol Chem; 2011 Oct; 286(43):37535-42. PubMed ID: 21896477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collagenolytic Matrix Metalloproteinase Activities toward Peptomeric Triple-Helical Substrates.
    Stawikowski MJ; Stawikowska R; Fields GB
    Biochemistry; 2015 May; 54(19):3110-21. PubMed ID: 25897652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of secreted and membrane-type matrix metalloproteinase activities based on substitutions and interruptions of triple-helical sequences.
    Minond D; Lauer-Fields JL; Cudic M; Overall CM; Pei D; Brew K; Moss ML; Fields GB
    Biochemistry; 2007 Mar; 46(12):3724-33. PubMed ID: 17338550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Edman degradation sequence analysis and matrix-assisted laser desorption/ionization mass spectrometry in designing substrates for matrix metalloproteinases.
    Lauer-Fields JL; Nagase H; Fields GB
    J Chromatogr A; 2000 Aug; 890(1):117-25. PubMed ID: 10976799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of collagen charge clusters in the modulation of matrix metalloproteinase activity.
    Lauer JL; Bhowmick M; Tokmina-Roszyk D; Lin Y; Van Doren SR; Fields GB
    J Biol Chem; 2014 Jan; 289(4):1981-92. PubMed ID: 24297171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase-1 takes advantage of the induced fit mechanism to cleave the triple-helical type I collagen molecule.
    O'Farrell TJ; Guo R; Hasegawa H; Pourmotabbed T
    Biochemistry; 2006 Dec; 45(51):15411-8. PubMed ID: 17176063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring metalloproteinase activity using synthetic fluorogenic substrates.
    Troeberg L; Nagase H
    Curr Protoc Protein Sci; 2004 Nov; Chapter 21():21.16.1-21.16.9. PubMed ID: 18429258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalytic- and ecto-domains of membrane type 1-matrix metalloproteinase have similar inhibition profiles but distinct endopeptidase activities.
    Hurst DR; Schwartz MA; Ghaffari MA; Jin Y; Tschesche H; Fields GB; Sang QX
    Biochem J; 2004 Feb; 377(Pt 3):775-9. PubMed ID: 14533979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical characterization of human collagenase-3.
    Knäuper V; López-Otin C; Smith B; Knight G; Murphy G
    J Biol Chem; 1996 Jan; 271(3):1544-50. PubMed ID: 8576151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substrate specificity of human collagenase 3 assessed using a phage-displayed peptide library.
    Deng SJ; Bickett DM; Mitchell JL; Lambert MH; Blackburn RK; Carter HL; Neugebauer J; Pahel G; Weiner MP; Moss ML
    J Biol Chem; 2000 Oct; 275(40):31422-7. PubMed ID: 10906330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments.
    Aimes RT; Quigley JP
    J Biol Chem; 1995 Mar; 270(11):5872-6. PubMed ID: 7890717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collagenase unwinds triple-helical collagen prior to peptide bond hydrolysis.
    Chung L; Dinakarpandian D; Yoshida N; Lauer-Fields JL; Fields GB; Visse R; Nagase H
    EMBO J; 2004 Aug; 23(15):3020-30. PubMed ID: 15257288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.